StemcellX Limited is a biotech enterprise developing market disrupting regenerative treatments for osteoarthritis.
| Website | https://stemcellx.com/developing-our-rd-facilities/ |
| Employees | 14 (8 on RocketReach) |
| Founded | 2016 |
| Industry | Biotechnology Research, Business Services General, Business Services |
| Keywords | Stem Cell Therapy, Regenerative Medicine, Osteoarthritis Treatment, Regenerative Treatments, Cell Therapy, Tissue Regeneration, Biotechnology, Biologics, Innovative Therapies, Biotech, Joint Regeneration, Cartilage Repair, Orthopedic Treatments, Advanced Therapies, Drug Development, Pharmaceutical Research, Medical Research, Health Technology, Clinical Trials |
| Competitors | Roche, Thermo Fisher Scientific, Corning Incorporated, Lonza, MilliporeSigma, Eurofins, STEMCELL Technologies, Miltenyi Biotec, PromoCell, BD Biosciences +33 more (view full list) |
| SIC | SIC Code 737 Companies, SIC Code 73 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 541512 Companies, NAICS Code 541 Companies, NAICS Code 54151 Companies, NAICS Code 5415 Companies |
Looking for a particular StemcellX employee's phone or email?
Endre Kiss-Toth is the Founder, CEO of StemcellX.
8 people are employed at StemcellX.
StemcellX is based in Sheffield, England.
The NAICS codes for StemcellX are [54, 541512, 541, 54151, 5415].
The SIC codes for StemcellX are [737, 73].